Publications for Cori M. Abikoff cabikoff@gmail.com

NYMC School of Medicine
  • Cairo, M. S., Talano, J. M., Moore, T. B., Weinberg, R., Keever-Taylor, C. A., Braniecki, S., . . . Abikoff, C., (2016). Familial haploidentical (FHI) allogeneic stem cell transplantation utilizing CD34 enrichment and T cell addback in children, adolescents & adults with high-risk sickle cell disease. rapid engraftment, low incidence of AGVHD, and sustained donor chimerism. Biology of Blood and Marrow Transplantation, 22(3), S367-S368.

  • Hamill, D., Baxter-Lowe, L. A., Shenoy, S., Moore, T. B., Morris, E., Abikoff, C., . . . Cairo, M. S. (2016). Robust donor chimerism and engraftment following familial haploidentical (FHI) (CD34 enriched and T-cell addback) allogeneic stem cell transplantation in patients with high risk sickle cell disease (SCD). Biology of Blood and Marrow Transplantation, 22(3), S95-S96. doi:10.1016/j.bbmt.2015.11.396

  • Mehta, B., Klejmont, L., Milone, M., Shaw, L., Morris, E., Abikoff, C., . . . Cairo, M. (2016). Pharmacokinetics and clinical outcomes of intravenous busulfan administered twice daily during conditioning in pediatric recipients prior to familial haploidentical (FHI) T-cell depleted (TCD) allogeneic hematopoietic stem cell transplantation (AlloHSCT) in high risk sickle cell disease (SCD). Pediatric Blood & Cancer, 63(Suppl S1), S17.  

  • Nash, M., Harrison, L., Shi, Q., El-Mallawany, N., Abikoff, C., Hochberg, J.,. . . Cairo, M. S. (2016). A pilot trial of unmatched human placental derived stem cells (HPDSCs) in conjunction with unrelated cord blood transplantation (UCBT) in children and young adults with malignant and non-malignant disease (IND 14949). Biology of Blood and Marrow Transplantation, 22(3), S143-S144. doi:10.1016/j.bbmt.2015.11.484

  • Talano, J., Abikoff, C., Moore, T. B., Weinberg, R. S., Braniecki, S., Chu, Y., . . . Cairo, M. S. (2016). Familial haploidentical (FHI) allogeneic stem cell transplantation utilizing CD34 enrichment and T cell addback in children, adolescents & adults with high-risk sickle cell disease. rapid engraftment, robust immune reconstitution, low-incidence of GVHD. Pediatric Blood & Cancer, 63(Suppl 1), S93-S94.

  • Abikoff, C. M. & Cairo, M. S. (2014). Reduced intensity conditioning and hematopoietic stem cell transplantation in pediatric nonmalignant disease: A new therapeutic paradigm. The Journal of Pediatrics, 164(5), 952-953.e2. doi:10.1016/j.jpeds.2014.01.061

  • Abikoff, C. M., Shi, Q., Giller, R., Pulsipher, M. A., Szabolcs, P., Hochberg, J., . . . Cairo, M. S. (2014). A pilot study of unrelated cord blood (UCB) transplantation and unmatched human placental derived stem cells (HPDSC) in pediatric malignant and non-malignant disease. Biology of Blood and Marrow Transplantation, 20(2), S137-138. doi:10.1016/j.bbmt.2013.12.211

  • Talano, J. A., Abikoff, C. M., Dozor, A. J., Friedman, D. M., Shi, Q., . . . Cairo, M. S (2014). Familial haploidentical (FHI) T-cell depleted (TCD) with T-cell addback stem cell transplantation for patients with high-risk sickle cell disease (SCD) (IND 14359) Biology of Blood and Marrow Transplantation, 20(2 Suppl), S135-S136. doi:10.1016/j.bbmt.2013.12.208